07630.HK
IMPACT THERAP-B
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 13.03
+15.51%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -1.05x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 4.13x
Liquidity & coverage
- Current ratio
- 8.06x
- Quick ratio
- 7.89x
- Cash ratio
- 7.51x
- Interest coverage
- -3.51x
- EBITDA / interest
- -3.43x
- Working capital
- HKD 1.2B
Cash & dividend
- FCF / debt
- -22.72x
- Cash flow / debt
- -22.62x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026